Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Epidermal keratinocyte cohesion is not a specific molecule or receptor but rather describes the collective process by which epidermal keratinocytes adhere to one another to maintain the structural integrity and barrier function of the skin. This cohesion is mediated by a complex network of cell-cell junctions (such as desmosomes), cytoskeletal elements (notably intermediate filaments composed of various keratins like K14 and K10), and associated regulatory proteins. Proper regulation of these components ensures effective cell adhesion, supports tissue architecture during differentiation and migration, and preserves epidermal homeostasis. Disruption in this process can result in pathological conditions such as blistering diseases or impaired wound healing[1][2]. Because "epidermal keratinocyte cohesion" refers to a biological property or process rather than an individual molecular target, it is not considered a canonical therapeutic target itself.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Epidermal keratinocyte cohesion.